Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

FLUMETHASONE PIVALATE & IODOCHLORHYDROXYQUIN

All products: general benefit

Locacorten Vioform Eardrops · DIN 00074454 · 0.02% & 1% · Ot Sol

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Locacorten Vioform Eardrops · DIN 00074454 Manufacturer: Knight Therapeutics Inc.; listing date 1996-10-01 Health Canada: Marketed since 2025-12-23 · brand LOCACORTEN VIOFORM EARDROPS · ATC S02CA02 FLUMETASONE AND ANTIINFECTIVES, S02CA02 FLUMETASONE AND ANTIINFECTIVES · form Drops · route Otic · ingredients FLUMETHASONE PIVALATE 0.02 %/W/V, CLIOQUINOL 1 %/W/V · company Knight therapeutics inc. · schedule Prescription
Check this DIN again · Health Canada product record

Locacorten Vioform Eardrops: Formulary list price $2.6300/unit (unit not stated in source; not the patient's cost)

Ministry pays: $2.6300 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=868 · Verify on the e-Formulary ↗ (DIN 00074454)

Source record
DIN 00074454: Locacorten Vioform Eardrops Raw flags: sec3=Y Item: 520800012; group id 593; item number 1552; lccId None; manufacturer id KNT Source form: Ot Sol; strength: 0.02% & 1% Recorded listing: General benefit Source prices (unrounded): $2.6300; ministry $2.6300 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00074454 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=868
Shortage status: resolved shortage (ended 2025-10-23); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00074454
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (52:08 Anti-Inflammatory Agents) and how they are covered

Matched class: 52:08 Anti-Inflammatory Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: DEXAMETHASONE, FLUOROMETHOLONE, FLUOROMETHOLONE ACETATE, KETOROLAC TROMETHAMINE, LODOXAMIDE TROMETHAMINE Some products covered without a code (check the product listing): BECLOMETHASONE DIPROPIONATE, BUDESONIDE, PREDNISOLONE ACETATE 52:08 Anti-Inflammatory Agents

BECLOMETHASONE DIPROPIONATE

· 3 products · General benefit (2), Listed, not a benefit (1) · strengths: 50mcg · Nas-Sp-200 Dose Pk

BUDESONIDE

· 3 products · General benefit (2), Listed, not a benefit (1) · strengths: 64mcg/Metered Dose, 100mcg/Metered Dose · Nas Sp-120 Dose Pk, Nas Sp-165 Dose Pk

DEXAMETHASONE

· 2 products · General benefit · strengths: 0.1% · Oph Oint-3.5g Pk, Oph Susp

FLUOROMETHOLONE

· 1 products · General benefit · strengths: 0.1% · Oph Susp

FLUOROMETHOLONE ACETATE

· 1 products · General benefit · strengths: 0.1% · Oph Susp

KETOROLAC TROMETHAMINE

· 3 products · General benefit · strengths: 0.5%, 0.45% w/v · Oph Sol, Oph Sol-0.4mL Vial Pk (Preservative-Free)

LODOXAMIDE TROMETHAMINE

· 1 products · General benefit · strengths: 0.1% · Oph Sol

PREDNISOLONE ACETATE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 1% · Oph Susp

AZELASTINE HCL & FLUTICASONE PROPIONATE

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 137mcg/Actuation&50mcg/Actuation · Nas-Sp-120 Dose Pk

BROMFENAC

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 0.07% w/v · Oph Sol (With Preservative)

FLUTICASONE PROPIONATE

· 4 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mcg/Actuation · Nas Sp-120 Dose Pk

MOMETASONE FUROATE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mcg/Dose · Nas Sp-140 Dose Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 52:08 and 2 more
Full class listing Related classes: 52:04 Anti-Infectives, 52:16 Local Anesthetics, 52:20 Miotics, 52:24 Mydriatics, 52:32 Vasoconstrictors, 52:36 Other Eye, Ear, Nose and Throat Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS LOCACORTEN VIOFORM EARDROPS (flumethasone pivalate and clioquinol drops) is indicated for: • otitis externa • otomycosis including that due to Aspergillus niger To reduce the development of drug-resistant bacteria and maintain the effectiveness of LOCACORTEN VIOFORM EARDROPS and other antibacterial drugs, LOCACORTEN VIOFORM EARDROPS should be used only to reduce the risk of infections that are proven or strongly suspected to be caused by susceptible bacteria. 1.1 Pediatrics Pediatrics (< 2 years of age): Health Canada has not authorized an indication in children under 2 years of age. 1.2 Geriatrics Geriatrics (>65 years of age): LOCACORTEN VIOFORM EARDROPS should be used with caution in geriatric patients, taking into consideration the greater frequency of decreased hepatic or renal function, of cardiovascular disease, and of concomitant disease or other drug therapy in this patient population. https://pdf.hres.ca/dpd_pm/00082925.PDF PM date: DEC 23, 2025 Source product: LOCACORTEN VIOFORM EARDROPS; DIN 00074454; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.